Emtricitabine is typically administered orally once a day in combination with other antiretroviral therapy (ART).

Emtricitabine has been studied at doses of 25 mg twice per day, 100 mg once daily, 100 mg twice daily, 200 mg once daily, and 200 mg twice per day.

Emtricitabine (200 mg) and tenofovir (300 mg) used as pre-exposure prophylaxis are prescribed as a once-daily oral tablet.